Introduction
Parvalbumin-expressing interneurons (PVIs) are fast-spiking GABAergic neurons that form inhibitory synapses onto either cell body or axon initial segment of pyramidal neurons. Via feed-forward and feed-back inhibitions, these interneurons exert a precise temporal control on the information flowing through their target neurons. Interconnected PVIs constitute a neuronal network able to synchronize the excitatory state of large numbers of neurons (Bartos et al., 2007) . Thus, PVIs coordinate the activity of neuronal assemblies in high-frequency synchrony (Cardin et al., 2009; Fuchs et al., 2007; Massi et al., 2012; Sohal et al., 2009) , thereby modulating the processing of information required for sensory perception, working memory, attention, learning and memory, and social behavior (Billingslea et al., 2014; Hu et al., 2014) .
Anomalies in PVIs and their associated networks are key pathological features of schizophrenia (SZ) (Beasley and Reynolds, 1997; Lewis et al., 2012) . Moreover, the specialized extracellular matrix (perineuronal nets, PNNs), which envelops many PVIs, is also abnormal in this disease (Enwright et al., 2016; Mauney et al., 2013; Pantazopoulos et al., 2015) . The immature developmental gene expression profile of PVIs in SZ (Gandal et al., 2012) suggests a defect in the proper phenotypic maturation of these interneurons, which are particularly sensitive to perturbations during brain development . Some of the proposed mechanisms underlying PVI anomalies in SZ are aberrant wiring of PVIs within neuronal networks, impaired glutamatergic inputs onto these interneurons and deleterious effects of neuroinflammation and oxidative stress (Lewis et al., 2012; Steullet et al., 2016) . Impaired NMDA receptor (NMDAR)-dependent signaling, which represents a major pathological pathway in SZ (Coyle et al., 2012; Poels et al., 2014; Steiner et al., 2013) , affects PVIs (Behrens et al., 2007) and neuronal network activity (Carlen et al., incides with the maturation of these interneurons and the PNN formation. Studies using antagonists targeting preferentially either GluN2A -or GluN2B-containing NMDARs suggest that GluN2A, not GluN2B, contribute to PVI maturation and phenotypic maintenance (Kinney et al., 2006; Zhang and Sun, 2011) . A disrupted function of GluN2A-containing NMDARs, as suggested by genetic studies, might therefore result in aberrant maturation and function of PVIs in some patients. Indeed, a few mutations in GRIN2A, the gene encoding GluN2A, have been identified in SZ (Hardingham and Do, 2016; Tarabeux et al., 2011) . The locus containing GRIN2A is also associated with schizophrenia in a large genome wide association study (Consortium, 2014) . The high-risk polymorphisms of GT repeats on the GRIN2A promoter give rise to reduced transcription (Liu et al., 2015) , and reduced GluN2A expression, have been reported in prefrontal cortex (Beneyto and Meador-Woodruff, 2008) and PVIs (Bitanihirwe et al., 2009) .
Although pharmacological manipulations support a role of GluN2A in development and phenotyping maintenance of PVIs, a demonstration of such function via genetic deletion of GRIN2A was missing. Moreover, how the GluN2A-mediated signaling disruption impact PVIs remain unclear. Redox dysregulation/oxidative stress, which is widely reported in schizophrenia (Do et al., 2009; Flatow et al., 2013; Kim et al., 2016; Yao and Keshavan, 2011) , is a common endpoint of many genetic and environmental risk factors leading to defects in PVIs and their associated PNNs in the prefrontal cortex, namely the anterior cingulate cortex (ACC) (Steullet et al., 2017) . In a recent perspective article, we briefly disclosed that PVI and PNN deficits are also accompanied with oxidative stress in GRIN2A KO mice. Here, we further explored the relationship between PVIs, PNNs and oxidative stress in the ACC of mice lacking GluN2A-containing NMDARs during postnatal development.
Methods

Animals
GRIN2A KO mice (Sakimura et al., 1995) were provided by A. Lüthi (University of Lausanne). They were backcrossed with C57BL/6J mice through many generations and housed under a 12-h light-dark cycle in groups of 3-5 individuals/cage. Experiments were performed on both sexes and approved by the Local Veterinary Office.
GBR12909 and N-acetylcysteine treatments
GBR12909 (GBR, 10 mg/kg i.p.) (BioTrend, Switzerland) was injected daily from postnatal days 10 to 20. The vehicle solution, a phosphate buffer saline solution (PBS), was used in control animals. Nacetylcysteine (NAC) (PharmaNAC, BioAdvantexPharma, Canada) was provided in drinking water (2.4 g/L) to the lactating mothers from postnatal days 7 to 20 (das Neves Duarte et al., 2012).
Perfusion and tissue preparation
For immunohistochemistry, mice were anesthetized and perfused with 4% paraformaldehyde. Coronal frozen sections (50-μm thick) of fixed brains were prepared and stored in ethylene glycol at − 20°C until use. For mRNA quantification, Western blots and GSH measurements, brains were quickly dissected out and sliced (2-mm thick) using a brain matrix. Slices were immediately stored at − 80°C until use. Tissue from the medial prefrontal cortex was extracted from frozen brain slices using a tissue punch.
Immunohistochemistry
Triple immunolabeling for oxidative stress, parvalbumin (PV), and perineuronal nets (PNNs) was performed as followed. An antibody against 8-oxo-2′-deoxyguanosine (8-oxo-dG), a product of DNA oxidation, was used as oxidative marker, while the PNNs were labeled with the lectin Wisteria floribunda Agglutinin (WFA), which binds the Nacetylgalactosamines in chondroitin sulfate proteoglycans Wang and Fawcett, 2012) . Brain sections containing the anterior cingulate cortex (ACC) were first incubated with PBS + Triton 0.3% + sodium azide (1 g/L) containing 2-3% normal horse serum, then placed for 48 h in a solution with a mouse monoclonal anti-8-oxodG (1:400; AMS Biotechnology, Switzerland) and a rabbit polyclonal anti-parvalbumin (PV) (1:2500; Swant Inc., Switzerland) primary antibody together with the biotin-conjugated WFA (1:2000; Sigma, Switzerland). Sections were then washed, incubated with fluorescent secondary antibody conjugates: goat anti-mouse Alexa 488 (1:300; Life Technologies, USA), goat anti-rabbit CY3 (1:300; Chemicon International, USA) and streptavidin 405 conjugate (1:300; Millipore Corporation, USA). For dual immunolabeling of Iba1 and CD68 to label microglia, normal donkey serum (2%) was used as blocking agent. Primary antibodies were a goat polyclonal anti-Iba1 (1:1000; Abcam, UK) and a rat monoclonal anti-CD68 (1:1500; Abcam) antibody. Secondary antibody conjugates were a chicken anti-goat Alexa 594 (1:300; Life Technologies, USA) and a chicken anti-rat Alexa 488 (1:300; Life Technologies, USA).
Sections were visualized and processed with a Zeiss confocal microscope equipped with ×10, × 40 and × 63 Plan-NEOFLUAR objectives. All peripherals were controlled with LSM 710 Quasar software (Carl Zeiss AG, Switzerland). With the triple immunolabeling of 8-oxodG, PV, and WFA, Z-stacks of 12 images (with a 2.13 μm interval) were scanned (1024 × 1024 pixels). Images were filtered with a Gaussian filter to remove background noise and sharpen cell profile contour. Only the inner 8 images of Z-stacks were used for the analyses. The stack images were merged in a tif file with Imaris, and further analyzed with Image J. Analyses were performed in a delineated region of interest (ROI) comprising the ACC (cg1) by an observer unaware of the experimental groups. For PV-IR, the number of PV-IR cell bodies was counted and the mean intensity of labeling (arbitrary unit) was measured separately within PV-IR cell bodies and PV-IR processes. PV-IR processes included all PV-labeled voxels that were not part of the identified PV-IR cell bodies. The mean intensity (arbitrary unit) was used as a measure for 8-oxo-dG-IR and WFA labeling. Because the image acquisition, the defined ROI, and the image analysis were slightly different to those used in Steullet et al. (2017) , the intensity of 8-oxo-dG (arbitrary unit) and the numbers of PV-IR cells/ROI in the present study were not identical to those reported in the above article. However irrespective of the analytical method used, the differences between experimental groups were similar. The number of PV-IR neurons surrounded by WFA-labeled PNNs was also counted in IMARIS software (Bitplane AG, Switzerland) as described previously (Cabungcal et al., 2013a) . Data are based on 4 non-contiguous sections per mouse. For dual Iba1 and CD68 immunolabeling, Z-stacks of 20 images (with a 1.2 μm interval) were scanned. The numbers of immunoreactive cells in the ACC ROI, using only the inner 18 images of Z-stacks, were counted using the spot tool of IMARIS. Data are based on two non-contiguous sections per mouse.
mRNA quantification
RNAs were extracted from the medial prefrontal cortex using RNeasy Mini Kit (Qiagen, Germany) as described in the manufacturer's protocol. cDNA were synthesized using 300 ng RNA in a reaction mixture containing RT-buffer 10×, 5.5 mM MgCl 2 , 2 mM dNTP, 0.4 U/ μl RNase Inhibitor, 2.5 μM Random Hexamers, and 1.25 U/μl RTase (Thermo Fisher Scientific, Waltham, USA). Taqman real time PCR was performed in a final volume of 20 μl containing 10 ng cDNA, 1 μl of selected probes mixed with 10 μl of TaqMan Universal PCR Master Mix (Thermo Fisher Scientific). Probes used were: GPX1 (Mm00656767_g1), GCLM (Mm00514996_m1), GCLC (Mm00802655_m1), TXNIP (Mm01265659_g1), SRXN1 (Mm00769566_m1), PPARGC1A (Mm01208835_m1), RPL27 (Rn00821099_g1), and β-Tubulin (TBB5) (Mm00495806_g1). Quantitative PCR was performed on Thermofisher 7500 Real-Time PCR System and the 7500 System SDS Software as established by the provider. Samples were run in duplicate. Values were normalized to the internal controls TBB5 and RPL27, and to a mixture of prefrontal samples. Data were analyzed using the ΔΔCt method.
Western blots
Tissue from the medial prefrontal cortex were lysed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% SDS, 1 mM dithiothreitol, 1 mM EDTA, 0.1% Triton, 0.6 mM phenylmethanesulfonyl fluoride, 30 mM NaF, 30 mM β-glycerophosphate, 0.2 mM orthovanadate and protease inhibitor cocktail (Roche)), sonicated and centrifuged for 15 min at 10000g. Tissue lysates were boiled at 95°C for 10 min in loading buffer (0.5 M Tris pH 6.8, Glycerol 30%, SDS 10%, beta-mercaptoethanol 5%, bromophenol blue 0.012%). Proteins were separated by SDS-PAGE on 12.5% nitrocellulose membranes, and transferred on PVDF membranes. After blocking in Tris-buffered saline (TBS) containing 2.5% milk, membranes were incubated overnight at 4°C with primary antibodies diluted in TBS with 01% Tween 20 and 3% BSA, followed by 1-h incubation with fluorescent secondary antibodies and a subsequent wash with TBS. Signals were visualized and analyzed with an Odyssey Clx imaging system (LI-COR Biosciences, Lincoln, USA) using β-actin for normalization. 2-cys peroxiredoxins (Prxs) were labeled irrespective of their redox state using a mouse anti-2-Cys Prxs (1:1000, Abcam), while the hyperoxidized Prxs (Prx-SO 2/3 H) were visualized with a rabbit antiPrx-SO 2/3 H (1:2000, Abcam). Normalization was performed using a mouse anti-β-actin (1:20,000, Abcam). Secondary antibodies were IRDye 800CW Goat anti-Mouse IgG (H + L) (1:10,000, LI-COR Biosciences), IRDye® 680RD Goat anti-Rabbit IgG (H + L) (1:10,000, LI-COR Biosciences).
GSH and oxidized GSH (GSSG) quantification
GSH and GSSG contents in medial prefrontal cortex were measured using the colorimetric Tietze method. Briefly, tissue was sonicated in ice-cold PBS (150 mM NaCl, 3 mM KCl, 1.5 mM KH 2 PO 4 , 7.9 mM Na 2 HPO 4, 2.5 mM EDTA, pH = 7.4). An aliquot was immediately reserved for protein quantification with the Advanced Protein Assay (Cytoskeleton, Denver, CO, USA). In the remaining lysate, proteins were precipitated by adding 10% sulfosalicylic acid (for a final 0.5% solution). The lysate was then centrifuged for 10 min at 10000 rpm at 4°C and triethanolamine was added to the collected supernatant to adjust the pH to~7.4. For the measurement of total GSH, an aliquot of supernatant was mixed with a freshly-made reaction solution containing at final concentration 0.5 U/ml GSH reductase from baker's yeast Fig. 1 . Delayed maturation of parvalbumin interneuron processes and perineuronal nets (PNNs), and sub-threshold oxidative stress in the anterior cingulate cortex (ACC) of GRIN2A KO mice. A Number of parvalbumin-immunoreactive (PV-IR) cells in ROI delineating the ACC. B Intensity (a.u.) of PV-IR within processes. C Intensity (a.u.) of labeling of WFA-PNNs. D Intensity (a.u.) of 8-oxo-dG-IR. Box plots depict medians and quartiles; bars show values in the 1.5 box length range. WT at PD20 (2 males, 2 females); WT at PD60 (2, 3); KO at PD20 (3, 3); KO at PD60 (6, 2). * p < 0.05, ** p < 0.01, *** p < = 0.001 (multiple comparisons using either Tukey HSD test or Games-Howell test).
(Sigma, St-Louis, MO, USA), 0.15 mM DTNB, 0.15 mM NADPH, and 1 mM EDTA. The rate of increase in absorbance at 405 nm, which measures the reduction of DTNB by GSH, is proportional to the total GSH. GSSG measurement was performed as for the total GSH. However, 2-vinylpyridine was first added to an aliquot of supernatant (final solution 1.8%) to derivatize GSH (1-h incubation) so only GSSG remained available for the reaction. For each sample, total GSH and GSSG were measured in duplicates. Concentrations of total GSH or GSSG in supernatants were determined by comparison with dilution series of GSH and GSSG solutions, respectively. Total GSH and GSSG contents in tissue were expressed in nmol/mg protein.
Electrophysiology
Mice were anesthetized with a mixture of ketamine/xylazine, and intracardiacally perfused with oxygenated sucrose-containing artificial cerebrospinal fluid (ACF) (in mM: 252 sucrose, 3 KCl, 2 MgSO 4 , 1.2 CaCl 2 , 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 10 glucose; pH 7.4) for~10 min prior to decapitation. Paracoronal slices (400-μm thick, Bregmã 1.4-0.6) containing the ACC were prepared with a vibroslicer in cold oxygenated sucrose-containing ACF, transferred into a "Haas" type interface chamber and superfused with oxygenated normal ACF (in mM: 126 NaCl, 3 KCl, 1 MgCl 2 , 1.2 CaCl 2 , 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 10 glucose; pH 7.4). ACF temperature was slowly raised from room temperature to~32°C. Electrophysiological recordings were performed at least 90 min after slicing. An ACF-filled glass electrode (~5 MΩ) was placed in the superficial part of layer V of the dorsal ACC (Cg1). Signals were band pass-filtered at 1-1000 Hz and digitized at 2 kHz. Oscillatory neuronal activity was generated with a mixture of kainate (0.8 μM), carbachol, (50 μM), and quinpirole (1 μM) in 5 mM KCl-containing ACF (Steullet et al., 2014) . Using the Welch method (IgorPro6 WaveMetrics, Portland, OR, USA), analysis of the power spectrum analyses was performed on a 60-s recording taken after 25-35 min incubation with the mixture of receptor agonists. The power spectrum was normalized so the power density between 100 and 1000 Hz was identical across recordings. The power density of fast oscillatory activity was calculated within the β band frequency (12-28 Hz). For each mouse, recordings were done bilaterally within 2 consecutive slices. Recordings that failed to display oscillatory activity with a peak frequency higher than 15 Hz were excluded from the final analysis.
Statistics
Statistics were performed with the SPPS software (IBM). Normality was tested by the Shapiro-Wilk test. When the variances were homogenous based on Levene's test, data were analyzed using univariate or multivariate analyses (general linear model), or Student t-test. Post hoc multiple comparisons were then performed using the Tukey HSD test. When the homogeneity of variances was not met, the Games-Howell test for multiple comparisons and the Welch's t-test were used. Quantification of mRNA expression was analyzed using a multivariate analysis (general linear model) with genotype and treatment as factors. Fig. 2 . A Representative images of parvalbumin, WFA, and 8-oxodG labeling in the ACC of PD20 WT and GRIN2A KO mice. Scale: 50 μm. B Higher magnification images showing PV-IR processing in superficial and deep layers of both WT and KO mice. Scale: 20 μm. C Higher magnification image illustrating the WFA staining associated with PV-IR cells. Scale: 20 μm. Note that in both B and C, the PV labeling was enhanced for display purpose only in order to better show PV-IR processes. Therefore, PV labeling in soma appears saturated in these images. D Schema showing the region of interest (ROI) in the ACC (cg1) in which quantification of PV-IR, 8-oxo-dG-IR and WFA staining was performed. CC: corpus callosum.
Results
Delayed maturation of PVIs and PNNs in GRIN2A KO mice
We first examined by immunohistochemistry parvalbumin-immunoreactive (PV-IR) neurons and PNNs in the ACC of GRIN2A KO and WT mice, at early postnatal age (PD20) and late adolescence/early adulthood (PD60). In WT mice, GluN2A is well expressed at PD20 (Matta et al., 2013; Zhang and Sun, 2011) when PVIs/PNNs undergo maturation. While the number of PV-IR cells did not differ between genotypes at both ages (Fig. 1a, 2) , the intensity of PV-IR in processes was significantly lower in young GRIN2A KO mice (Fig. 1b, 2) . Similar effect was observed regarding PV-IR intensity (a.u.) in soma: PD20 KO mice displayed significantly weaker PV-IR labeling (43 ± 2,mean ± sem) as compared to PD60 KO (56 ± 1, p = 0.001) and to PD60 WT mice (55 ± 3, p = 0.005). Likewise, PNN intensity was weaker in PD20, but not PD60 KO, as compared to age-matched WT mice (Fig. 1c,  2) . The proportion of PV-IR cells wrapped with WFA-labeled PNNs was also lower in KO compared to WT mice at both ages (PD20: 57.2 ± 0.6% in WT and 51.4 ± 1.1% in KO (mean ± sem), p = 0.004; PD60: 53.0 ± 1.1% in WT and 48.7 ± 0.4% in KO, p = 0.004, two-tailed Student t-test, Bonferroni corrected for multiple comparisons). These data indicate that absence of GluN2A delays maturation of PV-IR and PNNs. We also assessed oxidative stress in the ACC using an antibody against 8-oxo-dG. At both PD20 and PD60, we found no significant difference of 8-oxo-dG-IR between genotypes (Fig. 1d, 2) , although 8-oxo-dG-IR intensity was slightly more elevated in KO mice at both ages, as compared with age-matched WT mice.
PVIs and PNNs are vulnerable to an early postnatal oxidative insult in GRIN2A KO mice
The fact that the ACC of GRIN2A KO mice showed a delayed maturation of PNNs known to protect PVIs against oxidative stress (Cabungcal et al., 2013b) , suggested that an early-life oxidative insult might be detrimental to PVIs. This hypothesis was tested by applying an oxidative insult consisting of a daily treatment (from PD10 to 20) with the dopamine uptake inhibitor, GBR12909 (GBR). GBR elevates extracellular dopamine levels causing a subsequent generation of reactive oxygen species (ROS) and reactive compounds resulting from dopamine catabolism and auto-oxidation (Hastings et al., 1996; Hirrlinger et al., 2002) . Immediately following the 10-days treatment, GBR-treated KO mice displayed significantly higher 8-oxo-dG-IR in the ACC as compared to both WT groups (Fig. 3d, 4) . The number of PV-IR cells and the intensity of PV-IR in processes were also significantly lower in GBRtreated KO mice, as compared to PBS-and GBR-treated WT mice (Fig. 3a,b, 4) . PV-IR intensity in soma was also significantly lower in GBR-treated KO (46 ± 2) as compared to PBS-treated WT mice (56 ± 2, p = 0.023). Likewise, the intensity of WFA-labeled PNNs was weaker in GBR-treated KO mice than in both WT groups (Fig. 3c, 4) . Thus, a postnatal oxidative insult in KO mice increases oxidative stress, which is accompanied with reduction in number of PV-IR cells, further weakening of PV-labeling and WFA-labeled PNNs. The antioxidant, Nacetylcysteine (NAC), provided from PD7 to PD20, was sufficient to prevent all GBR effects in KO mice (Fig. 3e-h, 4) . Noteworthy, NAC restored PNNs to levels observed in naïve (Fig. 1c) , or PBS-treated WT mice (Fig. 3c) . Taken together, this shows that absence of GluN2A favors a susceptibility to oxidative stress-induced PVI/PNN defects.
Weakened antioxidant defenses in GRIN2A KO mice
As oxidative stress becomes prominent in the ACC of GRIN2A KO mice following a GBR treatment, we then explored the possible cause of such susceptibility to redox dysregulation. One hypothesis is that absence of GluN2A slightly compromises antioxidant systems. Synaptic NMDARs are indeed coupled with transcriptional control of several 
) of 8-oxo-dG-IR. WT PBS (5 males, 2 females); WT GBR (4, 3); KO PBS (3, 3); KO GBR (3, 4). E-H Treatment of KO mice with N-acetylcysteine (NAC) prevents GBR-induced oxidative stress (H), reduction in number of PV-IR cells (E) and PV-IR intensity in processes (F), and re-establishes normal levels of WFA-labeled PNNs (G).
For A-D: * p < = 0.05, ** p < = 0.01, *** p < =0.001 (multiple comparisons using the Tukey HSD test). For E-H: ***: p < 0.0005 (two-tailed Student or Welch's t-test). KO GBR (3 males, 2 females), KO GBR + NAC (4, 4). Box plots depict medians and quartiles; bars show values in the 1.5 box length range. Fig. 4 . Effect of early-life treatment with the dopamine uptake inhibitor, GBR12909 (GBR) on oxidative stress, parvalbumin interneurons, and perineuronal nets (PNNs) in the ACC of PD20 GRIN2A KO mice. Representative images of parvalbumin immunoreactivity, WFA-labeled PNNs, and 8-oxo-dG labeling in the ACC of PBS-treated and GBR-treated WT mice, PBS-treated and GBRtreated KO mice, and GBR-treated KO mice treated with N-acetylcysteine (NAC). Scale: 50 μm. Fig. 5 . Simplified scheme of the glutathione (GSH), thioredoxin (Trx), and peroxiredoxin (Prx) systems. Enzyme names are given in italic. GPx, glutathione peroxidase; GR, glutathione reductase; TrxR, thioredoxin reductase; Cys, cysteine; Glu, glutamate; GluCys, glutamylcysteine; GSSG, oxidized GSH; Txnip, thioredoxininteracting protein. Txnip interacts with reduced Trx to block the reduction by Trx of its substracts (e.g. oxidized 2-Cys Prxs). Here, Prx represent only the 2-cys Prxs. For simplification, only one of the sulfur group from the two cys residues in the Prx is presented in its different redox states (reduced: eSH, sulfenic: eSOH, sulfinic: eSO 2 H, disulfide: SeS). R can be a Prx or other molecules interacting with oxidized Prx to form disulfide bridges.
antioxidant systems (Baxter et al., 2015; Papadia et al., 2008) . Therefore, we quantified the expression of genes implicated in the glutathione system (i.e., GCLC, GCLM, GPX1), thioredoxin system (i.e., TXNIP) and peroxiredoxin (Prx) system (i.e., SRXN1) (Fig. 5) , as well as in mitochondria and antioxidant support (i.e., PPARGC1a) in medial prefrontal cortex of PD20 WT and KO mice treated either with GBR or PBS. The expression of these genes are affected by pharmacologicallyinduced NMDAR hypofunction (Baxter et al., 2015; Jiang et al., 2013; Papadia et al., 2008) . A multivariate analysis revealed a genotype (p = 0.021), but no treatment effect and no interaction (Fig. 6a) . In particular, there was a genotype effect on the expression of GCLM (p = 0.003) and SRXN1 (p = 0.007), which were both lower in KO compared to WT mice (Fig. 6a) . GCLM codes for the modulatory subunit of the glutamate-cysteine ligase, the key synthesizing enzyme of glutathione (GSH), while SRXN1 codes for sulfiredoxin 1 whose function is to reduce hyperoxidized Prxs (Prx-SO 2/3 H). Moreover, the lowest expression of 4 out of the 6 investigated genes was found in GBRtreated KO mice (Fig. 6a) . Thus, the absence of GluN2A decreases the transcription of some genes associated with the antioxidant defenses. Because of the reduced transcription of GCLM and SRXN1 in KO mice, we then examined whether levels of GSH, Prxs, and their respective redox state were altered in KO mice. Despite a reduced GCLM gene expression in KO mice, the total GSH content (sum of reduced and oxidized forms) was not different in both genotypes and not affected by the treatment (Fig. 6b) . However, the level of oxidized GSH (GSSG) was significantly higher in GBR-treated KO mice as compared to PBS-treated WT mice (Fig. 6c) . Regarding the Prxs, we found that GBR treatment increased the amount of Prxs (~21 kDa band corresponding to Prx 1 and Prx 2) in WT but not in KO mice (Fig. 6d,f) . The ratio between hyperoxidized Prxs (Prx-SO 2/3 H) and total Prxs (2-Cys Prx) was not significantly different between groups, although hyperoxidation tended to be higher in GBR-treated KO mice (Fig. 6e,f) . Thus in KO mice, the impaired upregulation of Prxs in response to GBR may limit the capacity of the Prx system to neutralize ROS. This may account for the more are normalized with β-actin as internal control. E Ratio between hyperoxidized 2-Cys Prxs (Prx-SO 2/3 H) and total 2-Cys Prxs at the 21 kDa band. WT PBS (3 males, 2 females); WT GBR (3, 2); KO PBS (3, 2); KO GBR (3, 2). For B-E: * p < =0.05, (*) p = 0.067 (multiple comparisons using Tukey HSD test). Box plots depict medians and quartiles; bars show values in the 1.5 box length range. F Representative Western blot showing the band for β-actin and the bands at 21 and 24 kDa which are recognized by the antibodies against 2-Cys Prxs and against Prx-SO 2/3 H. Note that the Prxs at 24 kDa was not different across groups and the Prx-SO 2/3 H band at 24 kDa was hardly visible and therefore not analyzed.
oxidized redox states of GSH and Prxs, as well as higher 8-oxo-dG-IR in GBR-treated KO mice. These results indicate that a lack of GluN2A is accompanied with subtle alterations in gene or protein expression of key elements of the GSH and Prx systems, which may contribute to the greater vulnerability of GRIN2A KO mice to oxidative insults as compared to WT mice.
An early postnatal oxidative insult has long-term effects on PVI and PNN integrity in GRIN2A KO mice
As early environmental stressors can cause long-term brain alterations in individuals with genetic susceptibility, we investigated the long-term effects of an early-life oxidative insult on the integrity of PVIs and PNNs in the ACC of PD60 GRIN2A KO mice. Previously, we have shown that a postnatal GBR treatment had no long-term effects on oxidative stress and PVI/PNN integrity in ACC of WT mice (Cabungcal et al., 2013a) . Therefore, we only compared GBR-treated KO mice with non-treated KO and WT mice. We observed that 8-oxo-dG-IR was significantly higher in GBR-treated KO than in non-treated KO and WT mice (Fig. 7d, 8) . The number of PV-IR cells, the intensity of PV-IR in processes and WFA-labeling were lower in GBR-treated KO mice compared to the other groups (Fig. 7a-c, 8) . PV-IR intensity in soma was also significantly lower in GBR-treated KO compared to PBS-treated KO mice (48 ± 2 vs. 56 ± 1, p = 0.011). The proportion of PV-IR cells enveloped with WFA-labeled PNNs was also lower in GBR-treated KO (40.9 ± 2.4%, mean ± sem) compared to non-treated WT (53.0 ± 1.1%) and KO mice (48.7 ± 0.4%) (p = 0.002 and p = 0.02, respectively, two-tailed Student t-test, Bonferroni corrected for multiple comparisons). These data demonstrate that an early-life oxidative insult causes persistent oxidative stress together with long-lasting impact on PVI and PNN integrity in the ACC of GRIN2A KO mice.
An early postnatal oxidative insult causes long-term microglia activation in GRIN2A KO mice
Since an early-life GBR treatment caused a long-term increase in oxidative stress in the ACC of KO mice, we explored whether this was accompanied with a persisting activation of microglia. Assessment of microglia was performed by immunohistochemistry using an antibody against Iba1, a microglia/macrophage-specific marker, and an antibody against CD68, a glycoprotein highly expressed in activated microglia. We found a significant difference in the number of CD68-IR cells, but not Iba1-IR cells, between PD60 non-treated WT and KO mice (Fig. 7e,f,  9 ). But most notably, the numbers of Iba1-IR and CD68-IR cells were higher in GBR-treated KO mice as compared to non-treated WT and KO mice. Such effect of GBR on microglia was not observed in WT mice . Moreover, Iba1-IR cells in GBR-treated KO mice displayed amoeboid shapes. These indicate that GRIN2A KO mice show a vulnerability for microglia activation and that an early-life oxidative insult promotes long-term phagocytic-like state of microglia in these mice.
3.6. An early postnatal oxidative insult has a modest long-term effect on local fast oscillatory neuronal activity in GRIN2A KO mice
We examined whether local fast oscillatory neuronal activity in the ACC of PD60 GRIN2A KO mice was also affected by an early-life GBR treatment. High-frequency oscillations (in β range: 12-28 Hz) were induced pharmacologically in ACC slices with the superfusion of carbachol, kainate and quinpirole. This fast oscillatory activity requires GABA A and AMPA receptors, as well as gap junctions (Steullet et al., 2014) , and is impaired when there is a reduced number of PV-IR cells in a mouse model of redox dysregulation (Cabungcal et al., 2013b) . First, we checked whether GBR had an effect on high-frequency oscillations in WT mice. We found no difference in oscillation power and peak frequency between PBS-and GBR-treated WT mice (Fig. 10a,c,e) . By contrast, GBR significantly decreased the oscillation power in KO mice (p = 0.009, one-tailed t-test; Fig. 10b,d ), but had no effect on the peak frequency (Fig. 10f) . Together, this indicates that an early-life oxidative insult impacts modestly local high-frequency oscillations in the ACC of late adolescent/young adult GRIN2A KO mice. 
Discussion
This study reveals that a lack of GluN2A leads to sub-threshold oxidative stress and delays maturation of PNNs and PVIs in the ACC. These effects appear to be caused by a dysregulated modulation of antioxidant systems. Consequently, an early-life oxidative insult results in persistent oxidative stress, microglia activation, decrease in PV-IR and WFA-labeled PNN integrity.
Our finding that GluN2A favors PNN and PVI maturation is consistent with the notion that NMDAR subunit plays an important role in cortical network refinement during postnatal development. GluN2A deletion impairs the development of orientation preference through sensory experience and weakens cortical plasticity to monocular deprivation in visual cortex (Fagiolini et al., 2003) . This plasticity can be restored by diazepam indicating an excitation/inhibition imbalance in young GRIN2A KO mice. While studies using a GluN2A-containing NMDAR antagonist suggest that GluN2A is implicated in both PVI maturation and phenotypic maintenance (Kinney et al., 2006; Zhang and Sun, 2011) , we demonstrate in this study that this receptor subtype plays an essential role in PVI maturation, but not phenotypic maintenance. Thus, a lack of GluN2A delays maturation of PNNs and PV-IR without impacting PV-IR and PNNs at late adolescence/early adulthood. PNN expression depends on neuronal activity (McRae et al., 2007) and requires calcium signaling (Dityatev et al., 2007) . Here, we show that the antioxidant NAC prevents the delayed PNN formation in GRIN2A KO mice. This strongly suggests that the slowing down of PNN maturation in absence of GluN2A is mostly driven by a redox dysregulation as evidenced by a sub-threshold level of oxidative stress, which is known to delay WFA-labeled PNN formation (Cabungcal et al., 2013b) . However, we cannot fully exclude that the boosting effect of NAC on PNN maturation in KO mice occurs via an upregulation of the glial glutamate transporter GLT-1 and the cystine-glutamate exchanger xCT (McClure et al., 2014) , leading to changes in extracellular glutamate levels and in activation of synaptic and extrasynaptic glutamate receptors also involved in PNN maturation. Our results suggest that the Fig. 8 . Long-term effects of early-life GBR treatment on oxidative stress, parvalbumin interneurons, and perineuronal nets (PNNs) in the ACC of PD60 GRIN2A KO mice. Representative images of parvalbumin immunoreactivity, WFA-labeled PNNs, and 8-oxo-dG labeling in the ACC of non-treated WT and KO mice, and GBR-treated KO mice. Scale: 50 μm. Fig. 9 . Long-term effects of early-life GBR treatment on microglia activation in the ACC of PD60 GRIN2A KO mice. Representative images of Iba1 and CD68 immunoreactivity in the ACC of non-treated WT and KO mice, and GBR-treated KO mice. Scale: 20 μm.
redox dysregulation in GRIN2A KO mice is caused by altered modulation of several antioxidant systems, including the GSH and Prx systems. Activation of synaptic NMDARs indeed regulates the transcription of genes associated with the GSH, Prx, and thioredoxin systems to support antioxidant defense and redox control in an activity-dependent manner (Baxter et al., 2015; Papadia et al., 2008) . The expression of genes associated with several antioxidant systems and mitochondrial function is impaired upon conditional deletion of the NR1 subunit in forebrain interneurons (Jiang et al., 2013) . NMDARs can modulate antioxidant systems via multiple transcription factors (e.g. CREB, FOXO, ATF4) (Papadia et al., 2008) . It is therefore possible that not one, but several pathways are slightly dysregulated by a lack of GluN2A. Indeed, further investigations will be required to identify the pathway(s) responsible for the subtle dysregulation of the antioxidant defense in GRIN2A KO mice. Additionally, a lack of GluN2A might reinforce the impact of GluN2B-mediated signaling cascades in neurons, one of them leading to NADPH oxidase-mediated superoxide production (Costa et al., 2012) . For example, a specific GluN2A antagonist increased superoxide production in prefrontal cortex of young mice (Powell et al., 2012) . Our data suggest that GluN2A-containing NMDARs sense network activity to maintain adequate redox control, which is particularly critical during postnatal development. Collectively, the present study proposes a novel mechanism by which GluN2A-containing NMDARs not only determines the direction of synaptic plasticity (Cho et al., 2009 ) but also mildly regulates redox-sensitive molecular mechanisms involved in cortical development and refinement. This includes regulation of the building up and maturation of PNNs. Environmental enrichment (EE) is also known to delay PNN development and modulate PNN integrity and composition. Depending on brain regions, EE weakens or enhances PNNs (Foscarin et al., 2011; Slaker et al., 2016) . However, the dynamic regulation of synthesis and removal of extracellular matrix components by EE likely involve mechanisms independent of oxidative stress.
The perturbed redox regulation and PNN deficit in ACC of PD20 GRIN2A KO mice also confer an increased susceptibility to an early-life oxidative insult. Previously, we have shown that a treatment with GBR leads to an excess of oxidative stress in ACC of young mice with a GSH deficit, but not in WT mice (Cabungcal et al., 2013a) . Likewise, a GBR treatment increases oxidative stress and decreases PV-IR and PNN integrity in ACC of PD20 GRIN2A KO. The GBR effects are prevented by NAC, proving the pivotal role of redox dysregulation. This is consistent with the notion that redox dysregulation/oxidative stress constitutes a convergent pathological pathway causing PNN/PVI anomalies in many animal models relevant to SZ (Steullet et al., 2017) . In GRIN2A KO mice, the impaired upregulation of Prxs in response to GBR may compromise the ability to adequately neutralize an excess of ROS production, leading to oxidative stress, PV-IR decrease and PNN deficit. Remarkably, the increased oxidative stress induced by an early-life GBR treatment persists until late adolescence/young adulthood together with the reduction of PV-IR, weakening of WFA-labeled PNNs, and activation of microglia in a phagocytic-like state. The reason for the persistence of oxidative stress and microglia activation following an early-life oxidative insult in GRIN2A KO mice might be directly linked to their sub-optimal antioxidant and redox regulation capacities. While an impaired redox regulation favors oxidative stress and microglia activation during an oxidative insult (i.e., GBR treatment), it may likewise prevent these glial cells to return into their inactivated state. Indeed, the phenotype of microglia is tightly regulated by the thiol redox status (Rojo et al., 2014) , whereby an appropriate reduced redox state is necessary for microglia inactivation. In a feed-forward process, the failure of microglia to switch back into a "resting" phenotype after being activated by an early insult could in turn maintain long-lasting oxidative stress leading to persistent PVI and PNN deficits.
In psychiatric diseases such as SZ, abnormal glutamatergic transmission, oxidative stress and microglia activation are commonly Fig. 10 . Long-term effect of early-life GBR treatment on local highfrequency oscillatory activity induced in ACC slices of PD60 GRIN2A KO mice. Power spectrum (median) of neuronal activity induced in ACC slices by a mixture of carbachol, kainate, and quinpirole in (A) PBS-and GBR-treated WT mice and in (B) PBSand GBR-treated KO mice. Power of β frequency (12-28 Hz) oscillations in (C) WT and (D) KO mice. Peak frequency of oscillations in (E) WT and (F) KO mice. Number of slices: 28 WT PBS, 25 WT GBR, 21 KO PBS, 34 KO GBR. Slices are from similar numbers of males and females. * p < 0.05 (two-tailed Student t-test). Box plots depict medians and quartiles; bars show values in the 1.5 box length range.
reported. The present study demonstrates that NMDAR hypofunction can be an upstream event of oxidative stress and neuroinflammation. This does not rule out, however, other possible scenarios whereby redox dysregulation or neuroinflammation could be primary cause for the disruption of the homeostasis between these tightly and reciprocally interconnected systems. In this context, the GluN2A subunit may play a pivotal role. Altered GluN2A expression is reported following social isolation, which also induces oxidative stress and microglia activation (Schiavone et al., 2012; Turnock-Jones et al., 2009 ): this might represent adaptive and/or compensatory mechanisms to stressors. Interestingly, GluN2A-containing NMDARs are themselves redox-sensitive and their function diminishes under oxidative conditions (Choi et al., 2001; Kohr et al., 1994) . A priori, this appears counterintuitive as GluN2A contributes to the regulation of antioxidant capacity and redox balance. One hypothesis is that a strong GluN2A-mediated signaling could be deleterious in some conditions. For instance, an overexpression of GluN2A in prefrontal cortex during adolescence is responsible for the anxious behavior and the decreased number of PV-IR cells caused by a maternal separation in rats (Ganguly et al., 2015) .
Conclusions
To conclude, a lack of GluN2A-dependent signaling confers a vulnerability to early-life stressors that affect PVIs and extracellular matrix via an inappropriate regulation of redox and immune systems. This could be relevant to SZ and but also other neurodevelopmental disorders associated with GRIN2A mutations such as epilepsy-aphasia. In the latter syndrome, same GRIN2A gene mutation can cause mild to severe symptoms, suggesting that other genetic and environment factors may play a role in the severity of the pathology (Burnashev and Szepetowski, 2015; Hardingham and Do, 2016) . Thus, antioxidant could be potentially beneficial to patients with a defect in GluN2A-containing NMDARs.
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